Spherix Inc news

   Watch this stock
Showing stories 1 - 10 of about 56   

Articles published

SPEX 1.76 -0.02 (-1.12%)
price chart
Spherix: A Focused Play On Patent Monetization
Spherix is a $71 million company owning over 300 patents that could turn into billions of dollars through litigation, licensing or outright sale.
Related articles »  
Spherix: Playing The Patent Game
For Spherix (NASDAQ: SPEX), they're a lifeblood. Headquartered in Tysons Corner, VA, Spherix monetizes intellectual property (IP) through lawsuits and licensing revenue.
Spherix Inc (SPEX) news: Spherix sues Cisco over "immense" patent infringement
Historically, Spherix has focused on biotech R&D, but obtained the IP - which was invented by Nortel - following an agreement with the Rockstar consortium that bought the patents from the bankrupt Canadian company.
Spherix Sues Cisco Over Alleged Patent Infringements  NASDAQ
Spherix sues Cisco over switches, routers patent infringement  Reuters
Related articles »  
Oversold Stocks: Halozyme Therapeutics (NASDAQ:HALO), Imperva Inc. (NYSE ...
Spherix Inc. (NASDAQ:SPEX) on 31 march announced a corporate update disclosing the 101 patents and patent applications acquired in December from Rockstar Consortium.
Thursday's Hot Stocks: Baxter International Inc. (BAX), DIRECTV (DTV), Spherix ...
Spherix Inc (NASDAQ:SPEX) jumped about 15% in pre-market trading on Thursday after disclosing it has commenced patent litigation in the United States District Court for the District of Delaware against Cisco Incorporated (CSCO) alleging that the San ...
Watch List: Relypsa Inc (NASDAQ:RLYP), Following Spherix (NASDAQ:SPEX)
Relypsa, Inc. (NASDAQ:RLYP) announced the pricing of an underwritten public offering of 3,591,836 shares of its common stock at a price to the public of $24.50 per share for gross proceeds of approximately $88 million.
Trending Stocks: Amyris Inc And Spherix Inc
NewYork, NY - (NISMAGAZINE) - 04/08/2014 - Amyris Inc (NASDAQ:AMRS) is involved in providing renewable compounds with very wide-ranging applications.
Trader's Alert: Opko Health Inc. (NYSE:OPK), GlaxoSmithKline plc (NYSE:GSK ...
Spherix Inc. (NASDAQ:SPEX) CEO Anthony Hayes buy 4000 shares of SPEX in a transaction dated on April 11, 2014. Spherix Inc. (NASDAQ:SPEX) shares were bought at an average price of $2.35 for total worth of $9,400.00. Spherix Inc. (NASDAQ:SPEX) ...
Spherix Inc(NASDAQ:SPEX) Dives Downwards On The Volumes
Dallas, Texas 04/01/2014 (FINANCIALSTRENDS) - Spherix Inc(NASDAQ:SPEX) has since lost some ground on the stock market, largely due to a dud volume-based transactions at the end of trading session.
Related articles »  
Here's why Citigroup Inc (NYSE:C), Spherix Inc (NASDAQ:SPEX) fell while ...
Citigroup Inc (NYSE:C) tumbled 5.40% on heavy volume Thursday as its capital plan was among five that were unable to pass Federal Reserve stress tests, while Bank of America Corp.
Stock's Buzzers - Spherix Inc (NASDAQ:SPEX), Cell Therapeutics, Inc ...  Techsonian (press release)
Stocks Trending New Low � Spherix Inc(NASDAQ:SPEX), KiOR Inc(NASDAQ ...  REM
Related articles »